Brazilian journal of otorhinolaryngology · 2014
[Larynx cancer: quality of life and voice after treatment].
Сравнительное исследованиеАннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rossi Vaneli Colombo, Fernandes Fernando Laffitte, Ferreira Maria Augusta Aliperti, Bento Lucas Ricci, Pereira Pablo Soares Gomes, Chone Carlos Takahiro
Аннотация
INTRODUCTION: Treatments for patients with laryngeal cancer often have an impact on physical, social, and psychological functions.
OBJECTIVE: To evaluate quality of life and voice in patients treated for advanced laryngeal cancer through surgery or exclusive chemoradiation.
METHODS: Retrospective cohort study with 30 patients free from disease: ten total laryngectomy patients without production of esophageal speech (ES); ten total laryngectomy patients with tracheoesophageal speech (TES), and ten with laryngeal speech. Quality of life was measured by SF-36, Voice-Related Quality of Life (V-RQOL), and Voice Handicap Index (VHI) protocols, applied on the same day.
RESULTS: The SF-36 showed that patients who received exclusive chemoradiotherapy had better quality of life than the TES and ES groups. The V-RQOL showed that the voice-related quality of life was lower in the ES group. In the VHI, the ES group showed higher scores for overall, emotional, functional, and organic VHI.
DISCUSSION: Quality of life and voice in patients treated with chemoradiotherapy was better than in patients treated surgically.
CONCLUSION: The type of medical treatment used in patients with laryngeal cancer can bring changes in quality of life and voice.
OBJECTIVE: To evaluate quality of life and voice in patients treated for advanced laryngeal cancer through surgery or exclusive chemoradiation.
METHODS: Retrospective cohort study with 30 patients free from disease: ten total laryngectomy patients without production of esophageal speech (ES); ten total laryngectomy patients with tracheoesophageal speech (TES), and ten with laryngeal speech. Quality of life was measured by SF-36, Voice-Related Quality of Life (V-RQOL), and Voice Handicap Index (VHI) protocols, applied on the same day.
RESULTS: The SF-36 showed that patients who received exclusive chemoradiotherapy had better quality of life than the TES and ES groups. The V-RQOL showed that the voice-related quality of life was lower in the ES group. In the VHI, the ES group showed higher scores for overall, emotional, functional, and organic VHI.
DISCUSSION: Quality of life and voice in patients treated with chemoradiotherapy was better than in patients treated surgically.
CONCLUSION: The type of medical treatment used in patients with laryngeal cancer can bring changes in quality of life and voice.